(Total Views: 1172)
Posted On: 09/01/2022 3:20:44 PM
Post# of 157708
From YMB
“Barring unforeseen announcements, the next item on known timeline is estimated mntbc study completion date of September 16th. GLTA Longs and Go Leronlimab. We currently have 9 months of additional data for OS and PFS vs SOC as requested by the FDA last December in response to our last BTD filing.”
“Barring unforeseen announcements, the next item on known timeline is estimated mntbc study completion date of September 16th. GLTA Longs and Go Leronlimab. We currently have 9 months of additional data for OS and PFS vs SOC as requested by the FDA last December in response to our last BTD filing.”
(5)
(0)
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
